JobWatch is a job posting and career development site designed exclusively for clinical research professionals of all levels. Job seekers can easily post and update resumes, apply directly for open positions and register for e-mail alerts announcing new positions. It is also the perfect resource to learn more about upcoming conferences on clinical research-related topics or register for training and academic degree programs for career development and advancement.
Sign up for your free account and find your next opportunity today!
Reach more professionals with your job posting. Jobs posted on JobWatch also appear complementary on ACRPs Career Center as part of our partnership. Your job listing receives extra exposure to the industry's largest community of clinical research professionals. Post Jobs Today.
The Board of the New Jersey Economic Development Authority (EDA) has approved Grow New Jersey (Grow NJ) tax credits to encourage the global pharmaceutical company Allergan, the U.S. subsidiary of Ireland-based Allergan, to remain in New Jersey and combine four existing company locations into a 431,495-square-foot facility in Madison.
Gov. Matt Bevin has announced CTI Clinical Trial and Consulting Services, a global, privately held company providing therapeutic expertise to the pharmaceutical and biotechnology industries, will relocate its headquarters to Covington with a $36.4 million investment projected to create up to 500 Kentucky-resident jobs.
Alliance for Clinical Research Excellence and Safety (ACRES) president and CEO, Dr. Greg Koski, has announced the appointment of Sara Monday as vice president for Site Development and Support. Monday becomes the newest member of the ACRES Executive Office, assuming responsibility for integrating systems initiatives related to advancing the interests of clinical research sites worldwide.
The Alliance for Regenerative Medicine (ARM), an international advocacy organization representing the gene and cellular therapies and broader regenerative medicine sector, announced that Matthew Patterson, president and CEO, Audentes Therapeutics, has been named vice chairman of ARM, effective immediately.